TMEM271: A Transmembrane Protein as a Drug Target and Biomarker

Target Name: TMEM271

NCBI ID: G112441426

TMEM271

Other Name(s): transmembrane protein 271 | TM271_HUMAN | Transmembrane protein 271

TMEM271: A Transmembrane Protein as a Drug Target and Biomarker

TMEM271, also known as transmembrane protein 271, is a gene that encodes a protein located in the membrane of various cell types, including neurons, muscle cells, and red blood cells. TMEM271 plays a crucial role in cell signaling, as it contributes to the formation and maintenance of tight junctions, which are a type of cell-cell adhesion that helps maintain tissue structure and function.

TMEM271 is a protein that is expressed in various cell types, including neurons, muscle cells, and red blood cells. It is a transmembrane protein, which means that it spans the cell membrane and is involved in the formation of tight junctions. tight junctions are a type of cell-cell adhesion that helps maintain tissue structure and function.

TMEM271 has been shown to be involved in a wide range of physiological processes in various cell types, including cell signaling, neurotransmission, and blood cell development. Its function is also of interest in the context of drug development, as it may serve as a potential drug target or biomarker.

Drug Target Potential

TMEM271 has been identified as a potential drug target due to its involvement in various signaling pathways. It has been shown to be involved in the regulation of neurotransmitter release from neurons, which is critical for neurotransmission. TMEM271 has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

TMEM271 may also serve as a potential biomarker for certain diseases, as its expression has been shown to be regulated in a variety of diseases, including neurodegenerative diseases, cancer, and cardiovascular disease.

Biomarker Potential

TMEM271 has been shown to be involved in the regulation of various physiological processes in various cell types, including cell signaling, neurotransmission, and blood cell development. Its function as a biomarker may be of interest in the context of disease diagnosis and treatment.

For example, TMEM271 has been shown to be involved in the regulation of neurotransmission in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Its expression may also be regulated in cancer, where it has been shown to play a role in the development and progression of certain types of cancer.

Furthermore, TMEM271 has been shown to be involved in the regulation of blood cell development, which may be of interest in the context of disease diagnosis and treatment. For example, its expression has been shown to be regulated in the development and function of red blood cells, which are responsible for carrying oxygen from the lungs to the rest of the body.

Conclusion

TMEM271 is a transmembrane protein that is involved in a wide range of physiological processes in various cell types. Its function as a protein that contributes to the formation and maintenance of tight junctions is of interest in the context of drug development, as it may serve as a potential drug target or biomarker. Further research is needed to fully understand the role of TMEM271 in various physiological processes and its potential as a drug target or biomarker.

Protein Name: Transmembrane Protein 271

The "TMEM271 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM271 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets